Ophidic accidents are among the problems of public health in Brazil. The components from bothropic venom are responsible for many systemic clinical complications resulting from envenomation. The present work aimed to analyse the systemic changes induced in mice after intraperitoneal administration of BmooTX-I, a myotoxic acidic phospholipase A 2 isolated from Bothrops moojeni venom. Urinalysis was performed and the following plasma biochemical markers were documented: urea, creatinine and uric acid (renal function); glucose and amylase (pancreatic function); alanine aminotransferase, alkaline phosphatase and gamma-GT (intra-and extrahepatic function); creatine kinase and enzymatic lactate (muscle function). Our results showed that after the intraperitoneal injection of BmooTX-I the urine of these animals showed glycosuria, proteinuria, haematuria, bacteriuria, bilirubinuria, polyuria and nitrite. The plasma biochemical analysis showed alterations in levels of urea, creatinine and uric acid. Amylase concentration was not altered significantly, but the plasma glucose increased significantly compared to controls. The plasma levels of alanine aminotransferase and alkaline phosphatase decreased and increased, respectively, in these same animals. On the other hand, the plasma γGT concentration did not undergo significant modification compared to the control group. The plasma concentration of CK increased, while the enzymatic lactate concentration decreased after the injection of the BmooTX-I. Therefore, in mice BmooTX-I is capable of causing systemic alterations which manifest as renal, muscular, hepatic and pancreatic impairment.
| INTRODUCTION
Bothrops genus snakes are the main snakes responsible for the ophidic accidents occurring in Latin America, [1] [2] [3] and the clinical complications resulting from the envenomation occur due to the composition of their venoms. The species Bothrops moojeni is an important snake of the Brazilian Cerrado, of epidemiological relevance, being responsible for many ophidian accidents. 4, 5 Bothropic venoms are secretions scientifically important and of great relevance clinically because they are composed of different enzymatic and nonenzymatic molecules that are responsible for the local and systemic clinical manifestations resulting from the envenomation. Systemic deleterious effects are related to disorders in hemostasis, interfering with the coagulation process and promoting systemic haemorrhagic events. 6 The components of these venoms are responsible for changes in many tissues including impairment of renal, pancreatic, hepatic and muscular function. These can progress to death. 3, [7] [8] [9] The nephrotoxicity can result in acute renal failure (ARF). 10, 11 Pancreatic toxicity is associated with amylase release into the blood which interferes with glucose metabolism, and can lead to pancreatic insufficiency. [12] [13] [14] Hepatic toxicity is associated with inflammation and necrosis, resulting in release of enzymatic markers of liver damage into the bloodstream. 15, 16 Systemic myotoxicity may be a result of skeletal muscle fibre lesions, culminating in the release of enzymatic biochemical markers and myoglobin into the blood. 17 These clinical manifestations occur due to the action of several proteins from snake venom, such as metalloproteinases (SVMPs), serine proteinases (SVSPs) and phospholipases A 2 (SVPLA 2 s) 18, 19 ( Figure 1A ).
Catalytically active phospholipases A 2 are enzymes that hydrolyze membrane phospholipids, which are on calcium dependent, resulting in the generation of free fatty acids, such as arachidonic acid and lysophospholipids. Arachidonic acid is a precursor of eicosanoids such as prostaglandins, leukotrienes and thromboxanes, important in intracellular signalling pathways that act in several biological functions. 20 The myotoxic activity of venoms of the Viperidae family results mainly in generation of phospholipases A 2 (PLA 2 s).
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The present work aimed to verify the systemic changes induced in mice after intraperitoneal administration of BmooTX-I (myotoxic acidic PLA 2 ) isolated from B. moojeni venom. For this the following biochemical markers were analysed: urea, creatinine and uric acid (renal); glucose and amylase (pancreatic); alanine aminotransferase-ALT, alkaline phosphatase-ALP and gamma-GT-γGT (intra-and extrahepatic function, respectively); creatine kinase-CK and enzymatic lactate (muscular), as well as the urinalysis.
| MATERIALS AND METHODS

| Venom
Desiccated B. moojeni snake venom was purchased from Bioagents Serpentarium (Batatais, SP, Brazil). This serpentarium is registered in the Brazilian Institute of Environment and Renewable Natural Resources (no 471 301). The crude venom was dried in a vacuum desiccator at room temperature immediately after milking and then stored at −20°C.
| Ethical approval
All experimental procedures followed the ethical parameters established by the Committee for Ethics in Animals Experimentation of Federal University of Uberlândia (Protocol number 037/16).
| Animals
Male Swiss mice (20-25 g) were kindly donated by Pentapharm do Brasil Comércio e Exportação Ltda and maintained in Bioterium of Physiological Sciences Area (ARFIS) of Universidade Federal de Uberlândia (UFU), under controlled light cycle (12/12 hours) and temperature (22 ± 2°C) with free access to food and water for 2 days prior to experiments.
| Estimation of protein concentration
The protein concentration of the BmooTX-I was determined using a UV absorption method that calculates concentration from absorbance at 280 nm, using a BioSpec-mini spectrophotometer (Shimadzu Biotech, Kyoto, Japan).
| Isolamento de BmooTX-I
Isolation of BmooTX-I was performed according to SantosFilho et al. 22 
| Treatment of animals
Male Swiss mice (n = 3) received intraperitoneal (i.p.) injection (10 μg) of BmooTX-I diluted in 100 μL of 0.9% saline solution and maintained in metabolic cages for 3, 6, 12 and 24 hours with free access to food and water during the experiments. Control animals received 100 μL of 0.9% saline i.p. and were kept under the same conditions. The BmooTX-I was administered i.p. since the results obtained were similar to other routes of administration (intramuscular and subcutaneous; data not shown). The glycemic parameter analysed at the time showed that the glucose elevation started more rapidly in the animals that received the venom i.p., followed by the intramuscular route and later by the subcutaneous route. Therefore, the i.p. route becomes advantageous, since the absorption process is faster through the portal vein via the peritoneal vasculature.
| Urine and Plasma
The urine was collected from the urine reservoir coupled in the lower part of the cages, quantified and used for the urinalysis. To obtain the plasma, the animals were anesthetized using 100 μL of sodium thiopental (160 mg/kg). The blood was removed by cardiac puncture, using heparin as anti-coagulant. Plasma was obtained by centrifugation of the whole blood at 900 xg for 6 minutes at room temperature. Plasma and urine obtained were used for the qualitative/quantitative analysis of target enzymes and metabolites by specific kits (Labtest Diagnostica ® , Lagoa Santa, MG, Brazil). The technical procedures adopted in all tests were carried out in strict accordance with the instructions of the manufacturer.
| Biochemical parameters
All plasma biochemical parameters were determined at 37°C in a Chemwell automatic analyser previously calibrated with Calibra H and checked with universal control serum Qualitrol using Labtest Diagnostica ® kits. All systemic parameters evaluated were compared with results obtained from control animals, treated only with 0.9% saline.
| Renal function
| Biochemical markers in plasma
Plasma urea, creatinine and uric acid concentrations were evaluated in the animals inoculated with BmooTX-I. The plasma urea and uric acid concentrations were measured by enzymatic kinetics in an ultraviolet photometry system. The plasma creatinine concentration was determined by colorimetric (alkaline picrate-Jaffé) method.
| Urinalysis
Routine urinalysis included physical examination of volume and colour as well as chemical parameters was measured with a commercial kit Uriquest ® Plus I, which quantifies bilirubin, ketone bodies, glucose, leucocytes, nitrite, protein, blood and urobilinogen.
| Pancreatic function
Pancreatic function via BmooTX-I was evaluated by determination of plasma glucose and amylase concentrations, using UV (Bonder and modified Mead) and colorimetric methods respectively.
| Intra-and extrahepatic function
Hepatic function was evaluated by identifying excess presence of obligate intracellular enzymes in the plasma. Alanine aminotransferase, ALP and gamma-glutamyl transferase (γGT) enzymes were measured using the methodologies modified Szasz, colorimetric and kinetic UV-IFCC, respectively.
| Muscle damage
Muscle damage was determined by measurement of creatine kinase (CK) and enzymatic lactate levels, using the methodologies UV-IFCC and Enzymatic-Trinder, respectively.
| Statistical analysis
The statistical analyses were carried out by ANOVA followed by Bonferroni's test (Prism 5.0; GraphPad Software Inc, La Jolla, CA, USA). Data are presented as mean ± SE (n = 3). Differences with P values of <5% were considered significant (P < 0.05). The software used in these analyses was GraphPad Prism 5.0.
| RESULTS
| Renal function
| Plasma biochemical parameters
The renal damage assay results showed that plasma urea concentration decreased significantly after 6 hours of BmooTX-I injection ( Figure 2A ). In contrast, the concentration of this metabolite increased significantly 24 hours after injection ( Figure 2A ). The plasma creatinine concentration decreased significantly after 6 hours of BmooTX-I administration ( Figure 2B ). There was a significant increase in the plasma concentration of uric acid after 24 hours of BmooTX-I injection ( Figure 2C ). Tables 1 and 2 show the urine physical and chemical parameters after injection of mice with saline (control) or BmooTX-I (tests), respectively. After 24 hours, polyuria was observed in the animals that received the enzyme when compared to the control animals (Table 1) . However, the density of both groups at all times did not change significantly (Table 1) . On the other hand, over time, the urine colour of the animals receiving the enzyme assumed a pattern ranging from yellow (3 and 6 hours), dark yellow (12 hours) to amber (24 hours), while urine from control animals did not assume amber colour ( Table 1) .
| Urine physical and chemical parameters
The semiquantitative results of the chemical parameters: blood, glucose, protein, urobilinogen, bilirubin, ketone bodies, nitrite, leucocytes and pH after administration of BmooTX-I and/or saline solution are presented in Table 2 . Haematuria was observed in animals given BmooTX-I, but not in control animals. This was seen at all times after enzyme administration times (3, 6, 12 and 24 hours; Table 2 ).
Regarding glucose, 50 mg/dL was detectable at 3 and 12 hours, and 100 mg/dL was detectable after 24 hours post injection. However at 6 hours this parameter appeared to be normal (Table 2) . Proteinuria was observed at 6 and 12 hours after injection (30 mg/dL), increasing further at the end of the experiment (100 mg/dL; Table 2 ). Bilirubin was detected in the treated group after 6, 12 and 24 hours. At 12 hours, the presence of bilirubin was more intense (++), whereas a the times of 6 and 24 hours, its presence seemed lower (−)( Table 2) .
The presence of nitrite was observed at all times after injection ( Table 2 ). For the pH value, a small reduction in the concentration of H + ions, 3 and 24 hours after the injection (Table 2) , was observed in the treated group. The other parameters such as urobilinogen, ketone bodies and leucocytes were not modified during the experiments (Table 2) .
| Pancreatic function
Amylase concentration was not affected by the injection ( Figure 3A) . The plasma concentration of glucose in these animals significantly increased after 6 hours of PLA 2 administration when compared to control animals ( Figure 3B ).
| Hepatic function
The plasma level of ALT significantly decreased 6 and 12 hours after injection ( Figure 4A ). However, there was significant increase in ALP, 6 and 24 hours after administration of BmooTX-I ( Figure 4B ). The plasma γGT concentration did not undergo significant modification compared to control ( Figure 4C ).
| Muscular damage
The plasma concentration of CK ( Figure 5A ) increased at 3 hours and the lactate concentration ( Figure 5B ) significantly decreased 24 hours after of injection.
| DISCUSSION
Renal toxicity is a common condition in bothropic snake envenomation. 10, 23, 24 Urinalysis is essential for the determination of physicochemical parameters in urine, such as volume, density, colour, pH, presence or absence of erythrocytes, proteins, glucose, bilirubin, leucocytes, ketone bodies, among others. 25, 26 Modification of urine colour was seen in the present study. The yellow colour, observed initially, intensified throughout the experiment, changing from dark yellow to amber in the animals inoculated with BmooTX-I ( Table 1) . Our results showed the presence of bilirubin in these animals, while the control animals did not have bilirubinuria (Table 2) . 27 Bilirubin is a metabolite of the heme, porphyrin commonly found in the body that makes up haemoglobin, myoglobin and cytochromes. 28, 29 The determination of bilirubin is clinically important for the diagnosis and treatment of possible haematological and hepatobiliary disorders and these findings indicate the rapid and severe course post injection.
28,30-32
The presence of proteins and erythrocytes in the urine is relatively frequent in ophidian accidents, especially haematuria 33 Table 2 . This may reflect the degree of renal damage that is caused by venoms which compromise the ultrafiltration capacity of the glomerular capsule, which in turn may explain the passage of larger molecules into the glomerular filtrate. 34 PLA 2 s from snake venoms of the Viperidae family are secreted toxins and classified into Asp49 PLA 2 s and Lys49 PLA 2 s. Asp49 PLA 2 s (aspartate residue at position 49) generally exhibit high catalytic activity, whereas Lys49 PLA 2 s (lysine residue at position 49) do not exhibit or exhibit low catalytic activity. 22, [35] [36] [37] The injected animals also showed polyuria (Table 1) and glycosuria (Table 2) . BmooTX-I, being an Asp49 PLA 2 , is capable of hydrolysis of membrane glycerophospholipid at the carbon-2 ester bond and release of arachidonic acid, precursor of eicosanoids (prostaglandins, thromboxanes and leukotrienes), substances involved in important biochemical, physiological and pharmacological functions. According to Santos-Filho et al, 22 BmooTX-I was able to induce the release of prostaglandin I 2 (PGI 2 ). Prostaglandins promote vasodilation, an effect capable of interfering with hemodynamics, resulting in increased rates of glomerular filtration and blood flow in the kidney 38 and, consequently, polyuria ( Figure 1B) . The increase in the amount of fluid eliminated by urine may also be related to hyperglycaemia and, consequently, to glycosuria.
39-41
The presence of glucose in the urine is not a physiologically normal condition, since this metabolite must be reabsorbed in the proximal convoluted tubule. Snake venom myotoxins can cause damage to the nephrons, 33 acting on tubular structures. Therefore, glycosuria can be explained by the myotoxic action of BmooTX-I, probably due to the functional impairment of the proximal tubule, which is responsible for the reabsorption of glucose. Another fact that corroborates with the glycosuria in the inoculated mice is the hyperglycaemia seen in these animals ( Figure 3B ), since the high concentration of plasma glucose exceeds the resorption capacity, so that this excess is eliminated in the urine.
Under normal physiological conditions, the nitrate obtained from the diet is excreted intact in the urine. However, under certain conditions, bacteria can convert nitrate to nitrite. Our results showed the presence of nitrite in urine of inoculated mice with BmooTX-I at all experimental times, unlike the control group (Table 2) . Thus, the presence of nitrite in the urine may be associated with a possible bacteriuria. [42] [43] [44] Changes in renal function may be assessed by the plasma quantification of nitrogen compounds such as urea, creatinine and uric acid. Urea is a nitrogenous compound synthesized in the liver from protein hydrolysis and catabolism of amino acids, so that the ammonium ion formed from the amino group of these amino acids is converted into urea by an enzyme cycle known as urea cycle, which in turn is transported by the bloodstream until the kidneys to be excreted in the urine in ureotelic animals. [45] [46] Our results showed a significant decrease in plasma urea concentration 6 hours after administration of toxin (Figure 2A) . However, this parameter increased further after 24 hours (Figure 2A ), which suggests that there is a late effect of the toxin, compromising glomerular filtration further.
Creatinine is constantly formed in the organism from dehydration of (phospho)creatine. According to Sodre et al, 45 increased plasma creatinine concentration is associated with damage in the nephrons. If so our results suggested that there was some rapid recovery as there was a significant decrease in plasma creatinine after 6 hours ( Figure 2B ). Uric acid is the product of purine catabolism. High levels of uric acid in the blood (hyperuricemia) can be caused by excessive production or deficient elimination of this compound. Most of the uric acid, originating from the degradation of purine, is excreted in the urine, therefore, high levels of this metabolite may be related to glomerular filtration problems, eliminating less uric acid and, consequently, increasing its plasma levels, which may be associated with renal changes and, even, renal failure. As with urea, our results showed a significant increase in plasma uric acid concentration after 24 hours (Figure 2C ), consistent with the hypothesis that there was ARF after 24 hours of PLA 2 administration.
Renal insufficiency is the main cause of mortality in envenomation, even when patients receive antiophidic therapy; that is, although antiophidic serum improves the patients' clinical condition, it is not able to prevent a possible renal failure condition. 25 According to the literature, ARF, also known as acute renal injury (ARI), is initiated mainly by the action of proteases and myotoxins from venom. 23, 24 It is often reversible, is characterized by a sudden decrease in kidney filtration capacity and, therefore, renal function, accompanied by a plasma increase (hours, days or weeks) of nitrogenous compounds, such as urea. 33, 47, 48 Therefore, since it is known that BmooTX-I has myotoxic action and that there was late plasma urea elevation, the ARI probably started 24 hours after administration of the toxin. With respect to pancreatic function there was no significant change in plasma amylase levels ( Figure 3A) . On the other hand, there was significant increase in plasma glucose concentration in the time of 6 hours ( Figure 3B ) when compared to control animals. This hyperglycaemia can be explained by a possible interference with the synthesis or secretion of insulin by the pancreas or, perhaps, by failures in the recognition of insulin by the receptors of this hormone. In both situations, the uptake of glucose by the cell is impaired, that is, the decrease in intracellular glucose, results hyperglycaemic condition. These results correlate with the glycosuria in these animals. 40 Hepatic toxicity with concomitant inflammation and necrosis is associated with the release of enzyme markers to the blood, due to changes in cells and increased cell membrane permeability. 15, 16 In this context, hepatic function can be analysed by determining the plasma levels of enzymes present in liver cells that are released into the blood in situations of liver injury. 49, 50 Ophidic venoms, including the Bothrops genus, can cause serious liver damage, usually resulting in the release of enzymes such as ALT, ALP and γ-GT 15,51,52 from the intracellular environmental to the blood plasma. Hepatotoxicity caused by acidic PLA 2 was first observed by Nisenbom et al, 53 toxin from Bothrops alternatus venom capable of severely compromising the liver. Alanine aminotransferase is a marker of liver damage found primarily in hepatocytes. In liver damage, the elevation of this transaminase in the blood is associated with increased membrane permeability or cell degradation. 54, 55 Membrane rupture of hepatocytes is most likely associated with ophidian venom phospholipases A 2 , because of hydrolysis of membrane glycerophospholipids. 56 However, according to our results, there was a significant decrease in plasma ALT concentration after 6 and 12 hours of administration of BmooTX-I ( Figure 4A ), inferring that there was probably no long term damage to hepatocytes as measured by ALT. Gamma-GT enzyme is found in high concentrations when there is obstructive damage of the biliary tract. There was no significant change in plasma levels of γ-GT after administration of BmooTX-I ( Figure 4C ), indicating that this PLA 2 was not able to induce hepatobiliary changes in the experimental animals. However, significant elevation of plasma (ALP) may indicate hepatobiliary damage (Figure 4B) .
Alkaline phosphatase is a nonspecific phosphomonohydrolase that removes phosphate groups from many molecules at alkaline pH. 57 However, another marker of hepatobiliary function is ALP which is synthesized in several tissues, particularly liver and bone. ALP is excreted in bile. There was a significant increase in plasma ALP levels after 6 and 24 hours of administration of BmooTX-I (Figure 4B) . Since ALP is a biochemical marker of hepatobiliary changes and that only its concentration increased in plasma when compared to ALT and γ-GT concentrations, it is possible that BmooTX-I was able to induce hepatobiliary dysfunctions, with possible cholestasis, since ALP is present in high concentrations in the membranes that surround the bile canaliculus. 34 There has probably been impairment of bile transport between the hepatocytes and the intestine, so that bilirubin, resulting from the destruction of senile or altered erythrocytes, is concentrated at high levels in the blood and therefore appears in the urine (Table 2) . Creatine kinase (CK) catalyzes the reversible reaction between creatine and phosphocreatine, using or synthesizing ATP according to muscular energy requirements. Thus, when there is energy demand in the muscle, the phosphate group of phosphocreatine is used in the synthesis of ATP. In the reverse situation, ATP phosphate phosphorylates creatine, resulting in phosphocreatine. 46, 58 Acidic PLA 2 s, commonly, have little or no myotoxic activity, whereas basic PLA 2 s have high myotoxic activity. However, BmooTX-I, although it is an acidic toxin, is capable of causing significant myotoxicity. 22 In the bothropic accident, serious muscular damages occur, especially in the first hours after the envenomation. Most likely, the lesions in the muscle are related to the activities of proteases and myotoxic phospholipases A 2 found in venoms of the genus Bothrops.
36,59
The enzyme CK is an important marker of muscle injury because it is at high plasma levels under these conditions, in view of its extravasation from the intracellular environment (muscle cells) to the extracellular (blood) environment. Thus, our results showed high plasma concentrations of CK in the first hours (3 hours; Figure 5A ) after BmooTX-I consistent with the results of Santos-Filho et al 22 and with previous data on muscle damage caused by B. moojeni venom when injected to animals. 60 According to Santos-Filho et al, 22 optical and electron microscopy analysis revealed that BmooTX-I was able to cause severe myonecrosis accompanied by inflammatory infiltrate. The gastrocnemius muscle fibres were extensively destroyed presenting different stages of degeneration and oedema. On the other hand, plasma lactate levels decreased after 24 hours of BmooTX-I inoculation ( Figure 5B ). Lactic acid is also a marker of muscle injury. 61 Skeletal muscle is one of the main sites responsible for lactate formation. This is formed from pyruvate (glycolysis final product) in the absence of oxygen (anaerobic pathway). In this context, the results showing the plasma lactate decrease, lead us to understand that BmooTX-I was not able to promote hypoxia Presumably the blood flow and, consequently, the tissue oxygen supply remained within the normal range. Corroborating these results, we highlight gluconeogenesis, an anabolic pathway by which lactate is converted to glucose in the liver, which may also explain the decrease in this metabolite in plasma.
In conclusion, the results described in this work show that BmooTX-I, myotoxic acidic PLA 2 isolated from B. moojeni snake venom, is capable of causing renal, pancreatic, hepatic and muscular systemic changes, which are certainly related to the serious complications resulting from B. moojeni envenomation. The present work aggregates information on systemic changes induced by B. moojeni venom and its components, showing the rage of affected sites and tissues, and highlights some of the possible therapies that will be required for the treatment of complications resulting from bothropic accidents.
